Pediatric anesthesia & critical care

Comparative acceptability and immediate behavioral response to different pediatric premedications: A systematic review and network meta-analysis

J Clin AnesthPublished Systematic review and Bayesian network meta-analysis of randomised trials

Authors' conclusion

Syrup-based oral midazolam offers a favorable balance between acceptability and behavioral response, making it a practical option for pediatric premedication.

Study context

Population
Children aged 1–12 years, ASA I–III, undergoing elective procedures under GA or sedation
Participants
1,858 children · 24 RCTs
Comparison
Pediatric premedications by drug, formulation and route
Methodological detailstwo separate network meta-analyses, SUCRA ranking, node-splitting
  • Two separate network meta-analyses
  • SUCRA ranking
  • Node-splitting

Pooled result

As reported in the abstract

  • Acceptability: highest with oral midazolam in commercial syrup and oral midazolam IV formulation mixed with syrup
  • Acceptability: low with nebulized ketamine, midazolam and dexmedetomidine
  • Behavioral response: most favorable with oral or intranasal clonidine, followed by oral midazolam mixed with syrup
  • Behavioral response: intranasal midazolam consistently poorest
  • Behavioral response: commercial midazolam syrup could not be analyzed
  • Ranked by SUCRA

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Comparative acceptability and immediate behavioral response to different pediatric premedications: A systematic review and network meta-analysis. J Clin Anesth. Published 21 November 2025. doi:10.1016/j.jclinane.2025.112077

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.